UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

Measuring Deterioration in International Classification of Functioning Domains of People With Multiple Sclerosis Who Are Ambulatory

Physical therapy, 2008-02, Vol.88 (2), p.176-190

2008

Link zum Volltext

Verfügbarkeit prüfen

Measures of Physical Functioning Predict Self-Reported Performance in Self-Care, Mobility, and Domestic Life in Ambulatory Persons With Multiple Sclerosis

Archives of physical medicine and rehabilitation, 2007-12, Vol.88 (12), p.1649-1657

2007

Link zum Volltext

Verfügbarkeit prüfen

A randomised, double blind, placebo controlled trial with vitamin D 3 as an add on treatment to interferon β-1b in patients with multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2012-05, Vol.83 (5), p.565-571

2012

Link zum Volltext

Verfügbarkeit prüfen

Multiple sclerosis in Finland 2018—Data from the national register

Acta neurologica Scandinavica, 2019-11, Vol.140 (5), p.303-311

2019

Link zum Volltext

Verfügbarkeit prüfen

Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland

Multiple sclerosis, 2010-08, Vol.16 (8), p.950-955

2010

Link zum Volltext

Verfügbarkeit prüfen

Reliability of physical functioning measures in ambulatory subjects with MS

Physiotherapy research international : the journal for researchers and clinicians in physical therapy, 2005-06, Vol.10 (2), p.93-109

2005

Link zum Volltext

Verfügbarkeit prüfen

Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells

Clinical and experimental immunology, 2008-02, Vol.151 (2), p.235-243

2008

Link zum Volltext

Verfügbarkeit prüfen

Physical functioning in multiple sclerosis: a population-based study in central Finland

Journal of rehabilitation medicine, 2006-11, Vol.38 (6), p.339-345

2006

Link zum Volltext

Verfügbarkeit prüfen

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2012-05, Vol.83 (5), p.565-571

2012

Link zum Volltext

Verfügbarkeit prüfen

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon [beta]-1b in patients with multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2012-05, Vol.83 (5), p.565

2012

Link zum Volltext

Verfügbarkeit prüfen

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon beta -1b in patients with multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2012-01, Vol.83 (5), p.565-571

2012

Link zum Volltext

Verfügbarkeit prüfen

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis

Neurology, 2012-03, Vol.78 (11), p.841

2012

Link zum Volltext

Verfügbarkeit prüfen

Selegiline Treatment Facilitates Recovery After Stroke

Neurorehabilitation and neural repair, 2001-01, Vol.15 (3), p.183-190

2001

Link zum Volltext

Verfügbarkeit prüfen

Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial

Lancet neurology, 2011-08, Vol.10 (8), p.691-701

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Measuring Deterioration in International Classification of Functioning Domains of People With Multiple Sclerosis Who Are Ambulatory

Measures of Physical Functioning Predict Self-Reported Performance in Self-Care, Mobility, and Domestic Life in Ambulatory Persons With Multiple Sclerosis

A randomised, double blind, placebo controlled trial with vitamin D 3 as an add on treatment to interferon β-1b in patients with multiple sclerosis

Multiple sclerosis in Finland 2018—Data from the national register

Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland

Reliability of physical functioning measures in ambulatory subjects with MS

Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells

Physical functioning in multiple sclerosis: a population-based study in central Finland

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon [beta]-1b in patients with multiple sclerosis

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon beta -1b in patients with multiple sclerosis

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis

Selegiline Treatment Facilitates Recovery After Stroke

Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial

Suchergebnisse filtern